Companies providing therapy and other mental health services to children are finding customers in school districts, despite federal funds drying up.
A health benefits platform and virtual provider announced funding rounds this week.
Some patients in the program will have access to popular weight loss medications including GLP-1s.
Big Health CEO Yael Berman said FDA clearances and a CMS proposal represent a turning point for the company and for digital therapeutics.
Telehealth vendors are seeking relief from the White House and Congress as their authority to remotely prescribe controlled substances is set to expire at year-end.
Ontogen Medtech said the moves are part of a broader strategy to offer services from design work to scalable production, to clients in health tech.
Health systems are increasingly pitting ambient AI documentation vendors against each other in head-to-head competition.
The warning follows a series of costly breaches for healthcare organizations.
Digital health ventures focused on oncology and employer benefits also announced recent funding news.
Despite the promise of remote patient monitoring, hospitals are grappling with how to get a return on their investments.
Pfizer launched a website Tuesday for scheduling vaccine appointments and virtual doctor visits, with prescriptions delivered to patients' doorsteps.
The move is part of Eli Lilly’s “all hands on deck” effort to ramp up supply of Zepbound and a similar drug for diabetes called Mounjaro amid shortages.
Executives from Providence, Ochsner Health and Hartford HealthCare weigh their options on artificial intelligence, and look to customize models when that's an option.
Chartis CEO Ken Graboys lays out a plan for the future of his company and of healthcare in America.